| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |